Alaunos Therapeutics | ZIOP - Assets


Alaunos Therapeutics reported $3.72M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Alaunos Therapeutics USD 3.72M 1.01M Sep/2025
Amgen USD 90.14B 2.24B Sep/2025
AstraZeneca USD 114.46B 2.03B Sep/2025
Baxter International USD 21.07B 21M Sep/2025
Biogen USD 29.21B 877.3M Sep/2025
Bioline Rx USD 39.8M 3.47M Sep/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Celltrion KRW 21.08T 530.63B Sep/2025
Corcept Therapeutics USD 823.61M 21.88M Sep/2025
Cspc Pharmaceutical CNY 46B 1.61B Jun/2025
Dianthus Therapeutics USD 577.44M 251.37M Sep/2025
Divis Laboratories Ltd INR 181.51B 12.19B Sep/2025
Gilead Sciences USD 58.53B 2.81B Sep/2025
GlaxoSmithKline GBP 61.34B 2.08B Sep/2025
Incyte USD 6.33B 509M Sep/2025
Ionis Pharmaceuticals USD 3.03B 47.96M Sep/2025
J&J USD 192.82B 573M Sep/2025
Kangmei Pharma CNY 13.68B 38.19M Sep/2025
Knight Therapeutics CAD 962.29M 16.93M Sep/2024
Laboratorios Farma EUR 799.88M 99.95M Dec/2023
Malin Corporation EUR 198.5M 70.1M Dec/2024
Medical Developments International AUD 66.4M 1.06M Jun/2025
Merck USD 129.55B 12.02B Sep/2025
Neuren Pharmaceuticals AUD 331.25M 78.46M Jun/2025
Novartis USD 107.29B 2.89B Sep/2025
Organigram Holdings CAD 562.21M 2.4M Sep/2025
Pfizer USD 208.73B 2.64B Sep/2025
Pharma Mar EUR 341.66M 6.59M Sep/2025
PTC Therapeutics USD 2.64B 9.54M Sep/2025
Qiagen NV USD 6.55B 729.74M Sep/2025
Regeneron Pharmaceuticals USD 40.56B 389.3M Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sartorius EUR 9.61B 413.4M Sep/2025
Sino Biopharmaceutical CNY 74.89B 9.49B Jun/2025
TG Therapeutics USD 1.03B 322.41M Sep/2025
Tilray USD 2.07B 1.33B Mar/2025
Zz Pientze Pharmaceu CNY 17.48B 1.23B Sep/2025